Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 43,810 shares at $327.48 ($13.9M) on 2023-04-12, disclosed to the SEC on 2023-04-14.
Scheduled sale ($13.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $325.65 | 2,917 | $950K | 6.8% |
| 2 | $325.65 | 2,917 | $950K | 6.8% |
| 3 | $326.46 | 10,357 | $3.4M | 24.3% |
| 4 | $326.46 | 10,357 | $3.4M | 24.3% |
| 5 | $327.48 | 8,026 | $2.6M | 18.9% |
| 6 | $327.48 | 8,026 |
| $2.6M |
| 18.9% |
| 7 | $0.00 | 1,210 | $0 | 0.0% |
| Total | $317.71 avg | 43,810 | $13.9M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |